Million Capital Return Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Million Capital Return Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Million Capital Return Program Today - Breaking & Trending Today

Theravance Biopharma, Inc. Reports Third Quarter 2022 Financial Results, Provides Business Update and Extends Tender Offer

Published: November 7, 2022

Reported another record quarter of YUPELRI® (revefenacin) net sales and profitability: $18.7 million Q3 2022 sales up 35% from Q3 2021 (TBPH implied 35%...

Source: prnewswire.com

Related Topics:

New YorkUnited StatesRicke WinninghamTheravance BiopharmaAndrew HindmanComputershare Trust CompanyCompany Offer To PurchaseMillion Capital Return ProgramInternational SymposiumDrug AdministrationTheravance Biopharma IncCompany Annual Report On FormCompany FormDevelopment Rd ExpensesTheravance Respiratory CompanySecurities ExchangeWhile Viatris IncViatris CompanyNone Of The CompanyAutonomic NervousRoyalty PharmaChief ExecutiveNapproved Drug ProductsTherapeutic Equivalence EvaluationsOrthostatic Hypotension Symptom Assessment